NCT06969586View on ClinicalTrials.gov

The Effect of Topical Rho-kinase Inhibitors on Corneas of Patients With Fuchs Endothelial Corneal Dystrophy

Enrolling by invitationOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

April 1, 2026

Study Completion Date

October 1, 2026

Conditions
Fuchs Endothelial Corneal DystrophyCataractGlaucoma
Interventions
DRUG

Netarsudil 0.02% Ophthalmic Solution

Topical Netarsudil 0.02% 1x daily for 30 days postoperatively

DRUG

artificial tear substitute

Topical artificial tear substitute 1x daily for 30 days postoperatively.

Trial Locations (1)

10000

University Hospital Dubrava, Zagreb

All Listed Sponsors
lead

University Hospital Dubrava

OTHER